Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,747 | -72,754 | -50,816 | -31,575 | -16,101 |
| Depreciation Amortization | 53 | 199 | 148 | 98 | 49 |
| Accounts payable and accrued liabilities | -1,043 | 1,542 | 483 | 145 | 484 |
| Other Working Capital | -71 | 2,695 | -945 | -2,761 | -2,236 |
| Other Operating Activity | 7,245 | 19,779 | 15,760 | 10,944 | 8,061 |
| Operating Cash Flow | $-21,563 | $-48,539 | $-35,370 | $-23,149 | $-9,743 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -15 | -8,000 | -8,000 | -8,000 | -8,000 |
| Investing Cash Flow | $-15 | $-8,000 | $-8,000 | $-8,000 | $-8,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 167,045 | 167,045 | 167,660 | N/A |
| Other Financing Activity | 0 | 130,075 | 129,757 | 129,757 | 128,885 |
| Financing Cash Flow | $0 | $297,120 | $296,802 | $297,417 | $128,885 |
| Beginning Cash Position | 284,309 | 43,728 | 43,728 | 43,728 | 43,728 |
| End Cash Position | 262,731 | 284,309 | 297,160 | 309,996 | 154,870 |
| Net Cash Flow | $-21,578 | $240,581 | $253,432 | $266,268 | $111,142 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,563 | -48,539 | -35,370 | -23,149 | -9,743 |
| Free Cash Flow | -21,563 | -48,539 | -35,370 | -23,149 | -9,743 |